Among the most successful fund investment fields, there are Medical, Biopharma. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Lyvgen Biopharma
The usual cause for the fund is to invest in rounds with 2 partakers. The meaningful sponsors for the fund in investment in the same round are 6 Dimensions Capital.
The high activity for fund was in 2018. The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars.
| Fund Name | Location |
| Concord Executive Group | Chiyoda, Japan |
| CT Dept. of Economic Development | Connecticut, Hartford, United States |
| Dongfang Jixing Xinxi | Beijing, Beijing, China |
| Eastone Huarui Technology | Beijing, Beijing, China |
| Eden Springs | Geneve, Switzerland, Vaud |
| ELADIET | Catalonia, Papiol, Spain |
| Golden Gate Capital | California, San Francisco, United States |
| Kitty Hawk Capital | Charlotte, North Carolina, United States |
| MPL Ventures | - |
| Stockhouse | British Columbia, Canada, Vancouver |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
| $30M | 18 Jul 2018 | Shanghai |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
| $30M | 18 Jul 2018 | Shanghai |
